Research map: Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study

Back to the article

Papers in this map

  1. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes · Siddhartha Jaiswal · 2014 · 4909 citations · Cited by this paper
  2. Expansion and safety profile of CD28‐costimulated anti‐CD19 CAR T cells in B‐cell lymphoma versus autoimmune disease · 2026 · Related
  3. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining · Janet D. Rowley · 1973 · 4333 citations · Cited by this paper
  4. Publication Only · 2026 · Related
  5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms · Joseph David Khoury · 2022 · 4220 citations · Cited by this paper
  6. Polygenic scores in the diagnosis of abnormal complete blood count values · 2026 · Related
  7. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene · Emma Shtivelman · 1986 · 478 citations · Cited by this paper
  8. Real‐world, multi‐omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS) · 2026 · Related
  9. Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia · Claude Preudhomme · 2010 · 392 citations · Cited by this paper
  10. From monoclonal to polyfunctional immunotherapy: Reprogramming CAR‐T‐cell therapy with oncolytic viruses in B‐cell malignancies · 2026 · Related
  11. St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem · Clay L. McLeod · 2021 · 278 citations · Cited by this paper
  12. Adult TWIST2 ‐high B‐ALL confirms metabolic association but reveals molecular heterogeneity · 2026 · Related
  13. Chronic myeloid leukemia (CML) with P190BCR-ABL: analysis of characteristics, outcomes, and prognostic significance · Dushyant Verma · 2009 · 180 citations · Cited by this paper
  14. Preclinical evaluation of the ROR1‐targeting antibody–drug conjugates zilovertamab vedotin and VLS‐211 against B‐cell ALL patient‐derived xenografts · 2026 · Related
  15. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias · Frits van Rhee · 1996 · 156 citations · Cited by this paper
  16. Persistent BCR::ABL1 ‐positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome‐positive ALL · 2026 · Related
  17. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status · Mathias Schmidt · 2014 · 143 citations · Cited by this paper
  18. EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies · 2026 · Related
  19. Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy · Tae‐Hyung Kim · 2016 · 142 citations · Cited by this paper
  20. CAR T‐cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma · 2026 · Related
  21. Prognostic impact ofDDX41germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study · Nicolas Duployez · 2022 · 86 citations · Cited by this paper
  22. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets · Shady Adnan Awad · 2020 · 76 citations · Cited by this paper
  23. Analysis of genomic breakpoints in p190 and p210 BCR–ABL indicate distinct mechanisms of formation · J Score · 2010 · 65 citations · Cited by this paper
  24. Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia · Zimu Gong · 2017 · 57 citations · Cited by this paper
  25. Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia · Thomas Burmeister · 2007 · 48 citations · Cited by this paper
  26. UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia · Nicolas Duployez · 2023 · 34 citations · Cited by this paper
  27. Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis · Animesh Dev Pardanani · 2009 · 29 citations · Cited by this paper
  28. Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients · David M. Ross · 2013 · 27 citations · Cited by this paper
  29. Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia · Aleksandra E Kamizela · 2025 · 20 citations · Cited by this paper
  30. Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases · Maymona G. Abdelmagid · 2022 · 13 citations · Cited by this paper
  31. Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis · Tatsuharu Ohno · 1998 · 9 citations · Cited by this paper
  32. Chronic Myeloid Leukemia With P190 BCR-ABL Translocation and Persistent Moderate Monocytosis: A Case Report. · Arianna Gatti · 2018 · 9 citations · Cited by this paper
  33. Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients · Lenka Hovorková · 2024 · 9 citations · Cited by this paper
  34. Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study · Hippolyte Guérineau · 2024 · 9 citations · Cited by this paper
  35. Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts · Preetesh Jain · 2013 · 8 citations · Cited by this paper
  36. A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment · Mariana Asinari · 2014 · 6 citations · Cited by this paper
  37. Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia · Benjamin Podvin · 2022 · 2 citations · Cited by this paper
  38. Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival · Pablo Romero-Morelos · 2024 · 2 citations · Cited by this paper
  39. A case of e1a2 (minor, P190) BCR-ABL1 -positive chronic myeloid leukemia in Korea · Yu Jeong Choi · 2021 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)